BOT 4.17% 37.5¢ botanix pharmaceuticals ltd

Ann: Investor Presentation, page-23

  1. 480 Posts.
    lightbulb Created with Sketch. 605
    Dar15, I suggest you read the outcome of the 2022 rosacea trial, which was also the last hurdle before acne phase 3 can start. Certainly further ahead than we were in 2020 as you assert. My guess is BOT might try to avoid significant dilution to advance further trials by waiting for the sweaty drug to get approval, perhaps even revenue. Further delay doesn’t worry me, I’ve been here long enough that I can wait because I can smell money and with less dilution the more for me.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.5¢
Change
0.015(4.17%)
Mkt cap ! $590.6M
Open High Low Value Volume
36.5¢ 40.0¢ 36.5¢ $10.56M 27.45M

Buyers (Bids)

No. Vol. Price($)
7 75348 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 514698 3
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.